Bioasis Technologies, Inc.

The market for initial public offerings in the US looks like it might be waking up from a month and a half nap with one biopharmaceutical company making it through the IPO window in mid-June and three

After its bid to acquire Canada's Bioasis Technologies, Inc. hit the rocks, UK group Biodexa Pharmaceuticals , formerly Midatech Pharma PLC , is looking to combine with Varian Biopharmaceuticals

Midatech Pharma PLC ’s hopes of survival have been badly damaged by its own shareholders who have voted against the UK firm's proposed merger with Bioasis Technologies, Inc. . With cash reserves rapi

Chiesi has made its biggest ever acquisition with the $1.48bn buyout of rare disease specialist company Amryt Pharma to further its US and rare disease ambitions. The privately owned, Italy-headqua